| [1] |
Newton K, Strasser A, Kayagaki N, et al. Cell death[J]. Cell, 2024, 187(2): 235-256.
|
| [2] |
Subbarao Malireddi RK, Kesavardhana S, Kanneganti TD. ZBP1 and TAK1: master regulators of NLRP3 inflammasome/pyroptosis, apoptosis, and necroptosis (PAN-optosis) [J]. Front Cell Infect Microbiol, 2019, 9: 406.
|
| [3] |
Galluzzi L, Vitale I, Aaronson SA, et al. Molecular mechanisms of cell death: recommendations of the nomenclature committee on cell death 2018[J]. Cell Death Differ, 2018, 25(3): 486-541.
|
| [4] |
Moujalled D, Strasser A, Liddell JR. Molecular mechanisms of cell death in neurological diseases[J]. Cell Death Differ, 2021, 28(7): 2029-2044.
|
| [5] |
Liu X, Xia SY, Zhang ZB, et al. Channelling inflammation: gasdermins in physiology and disease[J]. Nat Rev Drug Discov, 2021, 20(5): 384-405.
|
| [6] |
Man SM, Karki R, Kanneganti TD. Molecular mechanisms and functions of pyroptosis, inflammatory caspases and inflammasomes in infectious di-seases[J]. Immunol Rev, 2017, 277(1): 61-75.
|
| [7] |
Laurien L, Nagata M, Schünke H, et al. Autophosphorylation at serine 166 regulates RIP kinase 1-mediated cell death and inflammation[J]. Nat Commun, 2020, 11(1): 1747.
|
| [8] |
Samson AL, Zhang Y, Geoghegan ND, et al. MLKL trafficking and accumulation at the plasma membrane control the kinetics and threshold for necroptosis[J]. Nat Commun, 2020, 11: 3151.
|
| [9] |
Christgen S, Tweedell RE, Kanneganti TD. Programming inflammatory cell death for therapy[J]. Pharmacol Ther, 2022, 232: 108010.
|
| [10] |
Zheng M, Kanneganti TD. The regulation of the ZBP1-NLRP3 inflammasome and its implications in pyroptosis, apoptosis, and necroptosis (PANoptosis)[J]. Immunol Rev, 2020, 297(1): 26-38.
|
| [11] |
Lopes JP, Lionakis MS. Pathogenesis and virulence of Candida albicans [J]. Virulence, 2022, 13(1): 89-121.
|
| [12] |
Place DE, Lee S, Kanneganti TD. PANoptosis in microbial infection[J]. Curr Opin Microbiol, 2021, 59: 42-49.
|
| [13] |
Chen XT, Dai YF, Li YS, et al. Identification of cross-talk pathways and PANoptosis-related genes in periodontitis and Alzheimer’s disease by bioinformatics analysis and machine learning[J]. Front Aging Neurosci, 2024, 16: 1430290.
|
| [14] |
Christgen S, Zheng M, Kesavardhana S, et al. Identification of the PANoptosome: a molecular platform triggering pyroptosis, apoptosis, and necroptosis (PANoptosis) [J]. Front Cell Infect Microbiol, 2020, 10: 237.
|
| [15] |
Jiang S, Li H, Zhang L, et al. Generic diagramming platform (GDP): a comprehensive database of high-quality biomedical graphics[J]. Nucleic Acids Res, 2025, 53(d1): D1670-D1676.
|
| [16] |
Kuriakose T, Kanneganti TD. ZBP1: innate sensor regulating cell death and inflammation[J]. Trends Immunol, 2018, 39(2): 123-134.
|
| [17] |
Kesavardhana S, Subbarao Malireddi RK, Burton AR, et al. The Zα2 domain of ZBP1 is a molecular switch regulating influenza-induced PANoptosis and perinatal lethality during development[J]. J Biol Chem, 2020, 295(24): 8325-8330.
|
| [18] |
Banoth B, Tuladhar S, Karki R, et al. ZBP1 promotes fungi-induced inflammasome activation and pyroptosis, apoptosis, and necroptosis (PANoptosis)[J]. J Biol Chem, 2020, 295(52): 18276-18283.
|
| [19] |
Zheng M, Karki R, Vogel P, et al. Caspase-6 is a key regulator of innate immunity, inflammasome activation, and host defense[J]. Cell, 2020, 181(3): 674-687.e13.
|
| [20] |
Karki R, Lee S, Mall R, et al. ZBP1-dependent inflammatory cell death, PANoptosis, and cytokine storm disrupt IFN therapeutic efficacy during coronavirus infection[J]. Sci Immunol, 2022, 7(74): eabo6294.
|
| [21] |
Lee S, Karki R, Wang YQ, et al. AIM2 forms a complex with pyrin and ZBP1 to drive PANoptosis and host defence[J]. Nature, 2021, 597(7876): 415-419.
|
| [22] |
Cuny GD, Degterev A. RIPK protein kinase family: atypical lives of typical kinases[J]. Semin Cell Dev Biol, 2021, 109: 96-105.
|
| [23] |
Subbarao Malireddi RK, Kesavardhana S, Karki R, et al. RIPK1 distinctly regulates Yersinia-induced inflammatory cell death, PANoptosis[J]. Immunohorizons, 2020, 4(12): 789-796.
|
| [24] |
Dillon CP, Weinlich R, Rodriguez DA, et al. RIPK1 blocks early postnatal lethality mediated by caspase-8 and RIPK3[J]. Cell, 2014, 157(5): 1189-1202.
|
| [25] |
Dannappel M, Vlantis K, Kumari S, et al. RIPK1 maintains epithelial homeostasis by inhibiting apoptosis and necroptosis[J]. Nature, 2014, 513(7516): 90-94.
|
| [26] |
Jin L, Chen J, Liu XY, et al. The double life of RIPK1[J]. Mol Cell Oncol, 2016, 3(1): e1035690.
|
| [27] |
Geng JF, Ito Y, Shi LY, et al. Regulation of RIPK1 activation by TAK1-mediated phosphorylation dictates apoptosis and necroptosis[J]. Nat Commun, 2017, 8(1): 359.
|
| [28] |
Subbarao Malireddi RK, Gurung P, Kesavardhana S, et al. Innate immune priming in the absence of TAK1 drives RIPK1 kinase activity-independent pyroptosis, apoptosis, necroptosis, and inflammatory disease[J]. J Exp Med, 2020, 217(3): jem.20191644.
|
| [29] |
Sundaram B, Pandian N, Mall R, et al. NLRP12-PANoptosome activates PANoptosis and pathology in response to heme and PAMPs[J]. Cell, 2023, 186(13): 2783-2801.e20.
|
| [30] |
Henkel FDR, O’Neill LAJ. NLRP12 drives PANoptosis in response to heme[J]. Trends Immunol, 2023, 44(8): 574-576.
|
| [31] |
Zhang AP, Zhang CC, Zhang YH, et al. PANoptosis is a compound death in periodontitis: a systematic review of ex vivo and in vivo studies[J]. Oral Dis, 2024, 30(4): 1828-1842.
|
| [32] |
Aral K, Aral CA, Kapila Y. The role of caspase-8, caspase-9, and apoptosis inducing factor in perio-dontal disease[J]. J Periodontol, 2019, 90(3): 288-294.
|
| [33] |
Shi J, Li J, Su W, et al. Loss of periodontal ligament fibroblasts by RIPK3-MLKL-mediated necroptosis in the progress of chronic periodontitis[J]. Sci Rep, 2019, 9(1): 2902.
|
| [34] |
Bugueno IM, Batool F, Korah L, et al. Porphyromonas gingivalis differentially modulates apoptosome apoptotic peptidase activating factor 1 in epithelial cells and fibroblasts[J]. Am J Pathol, 2018, 188(2): 404-416.
|
| [35] |
Li YY, Cai Q, Li BS, et al. The effect of Porphyromonas gingivalis lipopolysaccharide on the pyroptosis of gingival fibroblasts[J]. Inflammation, 2021, 44(3): 846-858.
|
| [36] |
Chen Q, Liu XG, Wang DY, et al. Periodontal inflammation-triggered by periodontal ligament stem cell pyroptosis exacerbates periodontitis[J]. Front Cell Dev Biol, 2021, 9: 663037.
|
| [37] |
Duan Y, An W, Wu YX, et al. Tetramethylpyrazine reduces inflammation levels and the apoptosis of LPS-stimulated human periodontal ligament cells via the downregulation of miR-302b[J]. Int J Mol Med, 2020, 45(6): 1918-1926.
|
| [38] |
Oka S, Li XY, Sato F, et al. A deficiency of Dec2 triggers periodontal inflammation and pyroptosis[J]. J Periodontal Res, 2021, 56(3): 492-500.
|
| [39] |
Sun DD, Wu X, Lin SC, et al. Anti-apoptosis and anti-inflammation activity of circ_0097010 downregulation in lipopolysaccharide-stimulated periodontal ligament cells by miR-769-5p/Krüppel like factor 6 axis[J]. J Dent Sci, 2023, 18(1): 310-321.
|
| [40] |
Yang YN, Wang LX, Zhang HB, et al. Mixed lineage kinase domain-like pseudokinase-mediated necroptosis aggravates periodontitis progression[J]. J Mol Med (Berl), 2022, 100(1): 77-86.
|
| [41] |
Ke XJ, Lei L, Li H, et al. Manipulation of necroptosis by Porphyromonas gingivalis in periodontitis development[J]. Mol Immunol, 2016, 77: 8-13.
|
| [42] |
Li J, Shi JH, Pan Y, et al. Transcription modulation by CDK9 regulates inflammatory genes and RIPK3-MLKL-mediated necroptosis in periodontitis progression[J]. Sci Rep, 2019, 9(1): 17369.
|
| [43] |
Zhang KY, Chen XX, Zhou R, et al. Inhibition of gingival fibroblast necroptosis mediated by RIPK3/MLKL attenuates periodontitis[J]. J Clin Periodontol, 2023, 50(9): 1264-1279.
|
| [44] |
Jiang WY, Deng ZL, Dai XZ, et al. PANoptosis: a new insight into oral infectious diseases[J]. Front Immunol, 2021, 12: 789610.
|
| [45] |
Tomalka J, Ganesan S, Azodi E, et al. A novel role for the NLRC4 inflammasome in mucosal defenses against the fungal pathogen Candida albicans [J]. PLoS Pathog, 2011, 7(12): e1002379.
|
| [46] |
Cao MT, Wu ZX, Lou Q, et al. Dectin-1-induced RIPK1 and RIPK3 activation protects host against Candida albicans infection[J]. Cell Death Differ, 2019, 26(12): 2622-2636.
|
| [47] |
Wang X, Li Y, Liu S, et al. Direct activation of RIP3/MLKL-dependent necrosis by herpes simplex virus 1 (HSV-1) protein ICP6 triggers host antiviral defense[J]. Proc Natl Acad Sci U S A, 2014, 111(43): 15438-15443.
|
| [48] |
Yu XL, Li Y, Chen Q, et al. Herpes simplex virus 1 (HSV-1) and HSV-2 mediate species-specific modulations of programmed necrosis through the viral ribonucleotide reductase large subunit R1[J]. J Virol, 2015, 90(2): 1088-1095.
|
| [49] |
Guo HY, Omoto S, Harris PA, et al. Herpes simplex virus suppresses necroptosis in human cells[J]. Cell Host Microbe, 2015, 17(2): 243-251.
|
| [50] |
Siqueira JF Jr, Rôças IN. Present status and future directions: microbiology of endodontic infections[J]. Int Endod J, 2022, 55(): 512-530.
|
| [51] |
Liu L, Liang LP, Yang CH, et al. Extracellular vesicles of Fusobacterium nucleatum compromise intestinal barrier through targeting RIPK1-mediated cell death pathway[J]. Gut Microbes, 2021, 13(1): 1-20.
|
| [52] |
Liu H, Liu YX, Fan W, et al. Fusobacterium nucleatum triggers proinflammatory cell death via Z-DNA binding protein 1 in apical periodontitis[J]. Cell Commun Signal, 2022, 20(1): 196.
|
| [53] |
Ran S, Chu M, Gu S, et al. Enterococcus faecalis induces apoptosis and pyroptosis of human osteoblastic MG63 cells via the NLRP3 inflammasome[J]. Int Endod J, 2019, 52(1): 44-53.
|
| [54] |
Dai X, Deng Z, Liang Y, et al. Enterococcus faecalis induces necroptosis in human osteoblastic MG63 cells through the RIPK3/MLKL signalling pathway[J]. Int Endod J, 2020, 53(9): 1204-1215.
|
| [55] |
Chi DL, Lin XW, Meng QZ, et al. Real-time induction of macrophage apoptosis, pyroptosis, and necro-ptosis by Enterococcus faecalis OG1RF and two root canal isolated strains[J]. Front Cell Infect Microbiol, 2021, 11: 720147.
|
| [56] |
Mall R, Bynigeri RR, Karki R, et al. Pancancer transcriptomic profiling identifies key PANoptosis mar-kers as therapeutic targets for oncology[J]. NAR Cancer, 2022, 4(4): zcac033.
|
| [57] |
Karki R, Sundaram B, Sharma BR, et al. ADAR1 restricts ZBP1-mediated immune response and PANoptosis to promote tumorigenesis[J]. Cell Rep, 2021, 37(3): 109858.
|
| [58] |
Subbarao Malireddi RK, Karki R, Sundaram B, et al. Inflammatory cell death, PANoptosis, mediated by cytokines in diverse cancer lineages inhibits tumor growth[J]. Immunohorizons, 2021, 5(7): 568-580.
|
| [59] |
Yang P, Huang GZ, Li YL, et al. Identification of PANoptosis-related biomarkers and analysis of prognostic values in head and neck squamous cell carcinoma[J]. Sci Rep, 2024, 14(1): 9824.
|
| [60] |
Gao F, Zhang MH, Ying ZG, et al. A PANoptosis pattern to predict prognosis and immunotherapy response in head and neck squamous cell carcinoma[J]. Heliyon, 2024, 10(5): e27162.
|
| [61] |
Jiang XY, Fu TT, Huang L. PANoptosis: a new insight for oral diseases[J]. Mol Biol Rep, 2024, 51(1): 960.
|